Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Year-over-year gross profit growth rate
Percentile
P92
Near historical high
vs 2Y Ago
10x
Strong expansion
Streak
4 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 43.14% |
| Q2 2025 | 0.49% |
| Q1 2025 | -0.49% |
| Q4 2024 | -0.99% |
| Q3 2024 | -6.88% |
| Q2 2024 | 12.50% |
| Q1 2024 | -83.05% |
| Q4 2023 | 41.00% |
| Q3 2023 | 4.31% |
| Q2 2023 | 0.00% |
| Q1 2023 | 100.00% |
| Q4 2022 | 8.52% |
| Q3 2022 | -30.37% |
| Q2 2022 | -116.81% |
| Q1 2022 | 804.39% |
| Q4 2021 | -148.93% |
| Q3 2021 | -12.41% |
| Q2 2021 | -57.23% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 100.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |